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Ramaroson Andriantsitohaina1,2*
1 INSERM U1063, Stress Oxydant et Pathologies Métaboliques, Université d’Angers, Angers, France, 2 Centre Hospitalier
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Red wine polyphenol extracts (polyphenols) ameliorate cardiovascular and metabolic
disorders associated with obesity. Previously, we demonstrated that the alpha isoform
of estrogen receptor (ERα) triggers the vascular protection of polyphenols. Here, we
investigated the contribution of ERα on the effects of polyphenols on cardiovascular
and metabolic alterations associated with obesity. We used ovariectomized wild type
or ERα-deficient mice receiving standard (SD) or western (WD) diets, or SD and
WD containing polyphenols (SD+polyphenols and WD+polyphenols, respectively) over
a 12-week period. Body weight was measured during treatment. Echocardiography
examination was performed before sacrifice. Blood and tissues were sampled for
biochemical and functional analysis with respect to nitric oxide (NO•) and oxidative
stress. Vascular reactivity and liver mitochondrial complexes were analyzed. In WD-
fed mice, polyphenols reduced adiposity, plasma triglycerides and oxidative stress in
aorta, heart, adipose and liver tissues and enhanced NO• production in aorta and
liver. ERα deletion prevented or reduced the beneficial effects of polyphenols, especially
visceral adiposity, aortic and liver oxidative stresses and NO• bioavailability. ERα deletion,
however, had no effect on polyphenol’s ability to decrease the fat accumulation and
oxidative stress of subcutaneous adipose tissue. Also, ERα deletion did not modify
the decrease of ROS levels induced by polyphenols treatment in the visceral adipose
tissue and heart from WD-fed mice. Dietary supplementation of polyphenols remarkably
attenuates features of metabolic syndrome; these effects are partially mediated by
ERα-dependent mechanisms. This study demonstrates the therapeutic potential of this
extract in metabolic and cardiovascular alterations linked to excessive energy intake.
Keywords: estrogen receptor α, metabolic disorders, obesity, polyphenols, vascular disorders
Abbreviations: 5-HT, serotonin; A, amplitude; Ach, acetylcholine; AMPK, AMP-activated protein kinase; ANOVA, analysis
of variance; A.U., arbitrary units; bw, body weight; CDK, cyclin-dependent kinase; CMH, 1-hydroxy-3-methoxycarbonyl-
2,2,5,5-tetramethylpyrrolidine; COI, cardiac output index; CS, citrate synthase; DETC, Fe2+diethyldithiocarbamate; EF,
ejection fraction; EGCG, epigallocatechin-3-gallate; EPR, electron paramagnetic resonance; ERK, extracellular signal-
regulated kinase; ERα, estrogen receptor alpha; KO, Knock Out; LVEDD, diastolic left ventricular dimension; LVSED,
systolic left ventricular dimension; NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells; NO•, nitric oxide;
OVX, ovariectomized; PGC-1α, peroxisome proliferator-activated receptor gamma coactivator-1α; PPARγ, peroxisome
proliferator-activated receptors γ; PSS, physiological salt solution; ROS, reactive oxygen species; SD, standard diet; WD,
western diet; WT, wild type.
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INTRODUCTION
Obesity is defined as abnormal or excessive fat accumulation
associated with an increased risk of premature death due to
an increased incidence of metabolic diseases such as insulin
resistance, type 2 diabetes, dyslipidemia, non-alcoholic fatty liver
disease and coronary heart disease. Based on epidemiological
studies reporting a greater reduction in cardiovascular risk
and metabolic disorders associated with polyphenol-rich diet,
several dietary and pharmacological approaches have been
proposed to manage or prevent obesity and obesity-related
diseases. Polyphenols are bioactive food compounds primarily
present in fruits and vegetables and exert health benefits
protecting against metabolic and cardiovascular disturbances
(Andriantsitohaina et al., 2012). Polyphenols, in particular
those derived from red wine, possess anti-aggregatory platelet
activity, antioxidant and free radical scavenging properties
(Curin et al., 2006; Pechanova et al., 2006), as well as lipid-
and lipoprotein-lowering effects (Curin et al., 2006). We have
reported that red wine polyphenols (polyphenols) are powerful
vasodilators through the generation of NO• and can act on
the expression of protective genes of the cardiovascular system
(Andriambeloson et al., 1997). Importantly, in a rat model
of insulin-resistance, polyphenols prevent hypertension, cardiac
hypertrophy as well as ROS production in aorta and heart
(Bernátová et al., 2002; Al-Awwadi et al., 2005). Moreover, in
a context of obesity, polyphenols ameliorate glucose and lipid
metabolism, cardiac function, decrease peripheral resistance and
improve endothelium-dependent relaxation by enhancing NO•
bioavailability (Agouni et al., 2009).
Among the different classes of polyphenolic compounds
present in red wine, anthocyanins and oligomeric condensed
tannins exhibit pharmacological profiles comparable with
total extracts in terms of endothelial-dependent NO•-
mediated vasodilatation (Andriambeloson et al., 1998). Among
anthocyanins identified in wine, only delphinidin causes
endothelium-dependent relaxation, however, it is slightly less
potent than total extract (Andriambeloson et al., 1998).
A growing body of evidence demonstrates that estrogenic
signaling has an important role in obesity development (Musatov
et al., 2007; Xu et al., 2011). Indeed, 17 β-estradiol acts on
the α isoform of receptor (ERα) and protects against obesity-
related diseases (Musatov et al., 2007; Xu et al., 2011). Of
note, ERα has been identified as one of the key receptors
transducing vascular effects exerted by polyphenols, particularly
for delphinidin (Chalopin et al., 2010). These compounds interact
directly with ERα, activating molecular pathways including Src,
ERK1/2, eNOS, leading to endothelial NO• production, and
consequently vasorelaxation (Chalopin et al., 2010).
Based on these observations, the present study was designed
to investigate the contribution of ERα to the effect of polyphenols
in an experimental model of obesity and related metabolic
disorders using ERα WT or KO mice. In order to avoid
the cofounding effect of circulating estrogens on the effect
of polyphenols, known to possess structural similarities with
estrogens (Bowers et al., 2000; Chalopin et al., 2010), mice
were OVX. Animals were fed with a SD or a WD or
SD and WD containing polyphenols (SD+polyphenols and
WD+polyphenols, respectively). Particular emphasis has been
placed on body weight and fat deposition, glucose and lipid
metabolism, cardiac and vascular functions, tissue NO• and ROS
generation and hepatic mitochondrial function.
MATERIALS AND METHODS
Products
Polyphenols (exGrape R© TOTAL) were obtained from Grap’Sud
(Cruviers-Lascours, France). The phenolic composition of dry
powder in mg/g was: 2.72 hydroxybenzoic acids (gallic acid
and ethyl gallate), 315.60 flavan-3-ols (catechins, epicatechins,
B1, B2, B3, B4, galloyl, (epi)cat-epigallocatechin dimers, trimer),
0.81 stilbenes (trans-resveratrol, ε-viniferin, cis-resveratrol),
0.58 mg/g dihydroflavonol (astilbin), 3.62 hydroxycinnamic
acids (caftaric acid, coutaric acid, caffeic acid, fertaric acid,
cumaric acid), 15.10 flavonols (myricetin 3-O-glucuronide,
myricetin 3-O-glucoside, quercetin 3-O-galactoside, quercetin 3-
O-glucuronide, quercetin 3-O-glucoside, laricitrin 3-O-glucoside,
myricetin aglycone, syringetin glucoside, quercetin aglycone),
3.89 anthocyanins [(epi)cat-malvidin 3-O-glucoside, delphinidin
3-O glucoside, cyanidin 3-O-glucoside, petunidin 3-O-glucoside,
(malvidin + peonidin] 3-O-glucoside, pyranomalvidin pyruvic
acid, malv-ethyl-(epi)catechin, (malvidin + peonidin) acetyl
glucoside, pyranomalvidin 3-O-coumaroyl glucoside, petunidin
3-O-coumaroyl glucoside, (malvidin+ peonidin) 3-O-coumaroyl
glucoside, pyranomalvidin vinyl catechol, pyranomalvidin vinyl
phenol).
Polyphenols were mixed into a chow supplied in powder
form at 150 mg/kg. By taking into account that the weight
of the mouse is, in average, 22 g (please Table 1) and that
each mouse eats 4 g of chow per day, the mouse consumes
0.6 mg of polyphenols per day. Thus, the mouse received a
dose of polyphenols of 27.3 mg/kg/day. This dose is consistent
with our former studies (Diebolt et al., 2001; Baron-Menguy
et al., 2007; Agouni et al., 2009; Chalopin et al., 2010, 2014)
and is comparable to the concentration that produced maximal
relaxation of mouse aortic rings ex vivo. This was also compatible
with a human consumption of one to two glasses of red
wine per day and was in the range of that shown to possess
beneficial effects on oxidative damage in humans (Covas et al.,
2010).
SD (U8960P version 0066) and WD (U8958P version 0052) as
well as those containing polyphenols were obtained from SAFE
(Augy, France) (Supplemental Table 1).
SD contains 5% of fat based on its composition in g/kg which
represents 12% calories of total diet. With regard to WD, it
contains 21.5% of fat in g/kg that corresponds to 36.8% calories.
Ethics Statement
The local ethics committee (“Comité d’éthique en
expérimentation animale Pays de la Loire”) approved the
animal protocol followed in the present study (CEEA.2011.40).
This study was carried out in strict accordance with the
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guidelines and authorization with French Ministry of Agriculture
regulations based on European Community.
Animals and Protocol Design
Eight-week-old female C57bl/6 ERα WT or KO mice were
purchased from the Jackson Laboratories (Bar Harbor, ME) and
maintained at 23 ± 2◦C under a 12 h light-dark cycle. Mice were
OVX following a week of acclimation.
Mice were anesthetized using isoflurane (5% in induction
chamber, 2% in mask, flow of oxygen 1 L/minute). As
an analgesic, buprenorphine (0.1 mg/kg sc injection) was
administered pre- and post-surgery. During and after surgery,
mice were placed on heating pad.
After 7 days, both strains were randomly divided into four
groups SD, WD, SD + polyphenols and WD + polyphenols
during 12 weeks (n = 7/group). Mice were allowed ad libitum
access to water and diets. Animal body weight was measured
weekly. One week before sacrifice, mice were anesthetized
for echocardiography examination. After treatment, mice were
euthanized by gradient CO2 inhalation. First, we evaluated
the efficiency of ovariectomy assessed by uterus atrophy. The
comparison of uterus weight of OVX mice with uterus weight
of non-OVX mice was performed. Only the animals showing
uterus atrophy have been included in the study which explain
why the final number of animals was different in each group (WT
SD n = 5, WT SD +polyphenols n = 6, WT WD n = 5, WT
WD + polyphenols n = 7, KO SD n = 5, KO SD + polyphenols
n = 5, KO WD n = 4, KO WD + polyphenols n = 5). Then,
blood, tissues and organs were sampled for biochemical and/or
histological analysis.
Biochemical Analyses
Blood was collected by cardiac puncture at sacrifice and blood
was centrifuged for 15 min at 950 g and room temperature to
obtain plasma. Fasting glucose, triglycerides, total cholesterol,
LDL-cholesterol and HDL-cholesterol were measured using
KonelabTM 20 Clinical Chemistry Analyzer (Thermo Scientific,
Waltham, MA, USA).
Ex vivo Vascular Reactivity
Mice aorta was dissected and placed in modified Krebs–Henseleit
bicarbonate solution. Aortic rings were then mounted on a
wire myograph (Danish MyoTechnology, Aarhus, Denmark) and
filled with PSS, as previously described Chalopin et al. (2010).
Endothelium-dependent vasodilatation in response to Ach
(1 nmol/L to 10 mmol/L; Sigma–Aldrich, St. Quentin, Fallavier,
France) was studied in aortic rings with functional endothelium
pre-contracted with the thromboxane A2 agonist (9,11-dideoxy-
11a, 9a-epoxymethanoprostaglandin F2-a, U46619) (Sigma–
Aldrich) at 80% of their maximal response. Then, concentration-
response curves were constructed by cumulative application of
5-HT (1 nmol/L to 10 µmol/L; Sigma–Aldrich) to vessels with
functional endothelium.
Echocardiography Examination
In vivo transthoracic echocardiography was performed using a
VEVO 770 ultrasound machine from FUJIFILM Visualsonics
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(Toronto, ON, Canada) equipped with a 30-MHz imaging
transducer in mice anesthetized with isoflurane. Briefly, a two-
dimensional short axis view of the left ventricle was obtained in
order to record M-mode tracings. LVEDD, LVSED and COI were
evaluated.
Nitric Oxide (NO•) and Reactive Oxygen
Species (ROS) Determination by Electron
Paramagnetic Resonance (EPR)
Measurements were performed on a table-top x-band
spectrometer Miniscope (Magnettech, MS200, Berlin, Germany).
Detection of NO• production in aorta, visceral and subcutaneous
adipose tissues, heart and liver was performed using DETC
(Sigma–Aldrich) as a spin trap, whereas ROS detection
was performed using deferoxamine-chelated Krebs–Hepes
solution containing CMH (500 µmol/L, Noxygen, Mainz,
Germany), deferoxamine (25 µmol/L, Sigma–Aldrich), and
DETC (5 µmol/L) (Agouni et al., 2009). Signal values are
expressed in A.U. as data was corrected for total amplitude/mg
weight of dried tissue, as previously described Agouni et al.
(2009).
Mitochondrial Enzyme Activities in Liver
Activities of CS, complex I, II, and IV of mitochondria were
spectrophotometrically measured on liver homogenates at 37◦C
and expressed in nmol of product formed per minute and per mg
of protein in homogenates, as previously described Mingorance
et al. (2012).
Statistical Analysis
Data were expressed as mean ± SEM and n represents the
number of animals. The statistical software GraphPad Prism 7.0
(GraphPad Software Inc., San Diego, CA, USA) was used for
data analysis. The difference between groups was performed by
repeated measures two-way ANOVA for the evolution of body
weight gain. For all the other experiments one-way ANOVA was
applied. When ANOVA demonstrated a significant interaction
between variables, post hoc analyses were performed by the
multiple-comparison Holm–Sidak’s test. P< 0.05 was considered
to be statistically significant.
RESULTS
Effect of Polyphenols on Body and Organ
Weight
WD diet induced a time-dependent increase in body weight
gain in WT mice compared to WT SD-fed mice (P < 0.0001)
(Figure 1). Polyphenols did not modify body weight of WT mice
fed with SD (Table 1) and it did not significantly reduce the
body weight gain induced by WD compared to control. In KO
mice, WD increased body weight gain (P < 0.0001) that was not
significantly reduced upon polyphenol treatment.
In WT mice fed with WD, the increase of body weight
was associated with higher visceral and subcutaneous adiposity
compared to WT SD mice (P = 0.0002 and P = 0.0045,
FIGURE 1 | The evolution of (A,B) body weight gain of ERα WT (A) and KO
(B) mice receiving normal diet (SD), western diet (WD), or SD and WD
containing polyphenols (SD + polyphenols and WD + polyphenols,
respectively) during 12 weeks. The body weight was recorded twice a week.
The data are expressed as the mean ± SEM. Statistical analyses were
performed by repeated measures two-way ANOVA and Holm–Sidak’s
post hoc test, ∗∗∗∗P < 0.0001 vs. WT SD, §§§§ P < 0.0001vs. WT
SD + RWP, † † †P < 0.001 vs. KO SD, ¤¤¤¤P < 0.0001 vs. KO SD + RWP.
respectively) (Table 1). Interestingly, polyphenols decreased
visceral (P = 0.0022) but not subcutaneous adiposity compared
to WT WD mice. In mice lacking ERα, WD augmented
subcutaneous adipose tissue weight (P < 0.0001). Polyphenols
failed to modify the increase in weight of adipose tissues in mice
lacking ERα treated with WD (Table 1).
Liver and heart weight was not modified upon WD and
polyphenols supplementation in WT mice compared to SD-fed
mice. Deletion of ERα decreased liver weight in mice fed with SD
and WD (P = 0.0053 and P = 0.0041, respectively) compared to
WT groups. Polyphenols had no effect on both liver and heart
weight.
Altogether, these data show that the ability of polyphenols to
reduce adiposity requires the presence of ERα.
Effect of Polyphenols on Biochemical
Plasma Parameters
Plasma levels of glucose, triglycerides and cholesterol were
greater in WT mice fed with WD compared to WT SD mice
(P = 0.0025, P = 0.0017 and P = 0.00781, respectively)
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(Figure 2). HDL/LDL ratio (Figure 2) and insulin levels
(1.7 ± 0.3 vs. 1.8 ± 0.6 ng/dL) were not different in WT SD and
WT WD mice.
Polyphenols normalized circulating levels of triglycerides
(P = 0.0115) without affecting glycemia, cholesterolemia and
HDL/LDL ratio in WT mice fed with WD.
Deletion of ERα increased HDL/LDL ratio in SD-fed mice
compared to WT SD group (P = 0.0086), without modifications
of other evaluated parameters.
WD significantly enhanced cholesterol levels in KO mice
fed with polyphenols compared to those fed with SD plus
polyphenols (P = 0.0202). Diet supplementation with
polyphenols did not modify circulating parameters in KO
mice.
Thus, ERα was involved in the WD-induced hyperglycemia
and hypertriglyceridemia and polyphenols did not further modify
these parameters.
Effects of Polyphenols on Aorta
Both WD and polyphenols did not modify the endothelium-
dependent relaxation to Ach in aortic rings from WT mice
(Figure 3A). Deletion of ERα did not affect relaxation to
Ach compared WT mice (Figure 3B). In aortas from ERα
KO mice, WD significantly reduced maximal response to Ach
when compared to that from KO SD-fed mice (P = 0.0002).
Polyphenols treatment did not significantly affect relaxation to
Ach in aorta from both SD and WD-treated mice.
5-HT induced a concentration-dependent contraction in
aortic rings from all groups of mice. 5-HT response was
significantly decreased in mice receiving WD compared to those
receiving SD (P = 0.0001) (Figure 3C). Polyphenols failed
to improve the contractile response to 5-HT in WT mice
independently of diet. Although not statistically significant, in
the aortic rings from KO mice, the maximal contraction induced
by 5-HT was lower than those of WT mice. Neither WD
nor polyphenols modified 5-HT-evoked responses in aorta for
ERα-deficient mice (Figure 3D).
Effects of Polyphenols on Heart
Echocardiographic analysis showed no significant modifications
in heart structure and function, whatever the mouse strains and
diets (Table 2).
Effect of Polyphenols on Liver
In WT mice, among all liver enzyme activities tested, WD only
reduced complex II activity (P = 0.0092) (Figure 4C). Neither
polyphenols nor deletion of ERα had any effect on enzyme
activity in SD-fed mice (Figures 4A,B,D). Complex II activity was
greater in KO compared to WT mice fed with WD (P = 0.0026).
Effect of Polyphenols on NO• Production
Aorta from WT mice fed with WD displayed a decrease in
NO• production which was not significantly different from that
observed in the SD group (Figure 5A). Polyphenols caused a
significant (P = 0.00105) increase in NO• production in WT
animals fed a WD, but not in those fed a SD. NO• production
in ERα-deficient mice fed with WD was lower than those of SD
group (P = 0.0177) (Figure 5A). Polyphenols did not modify
NO• production in aortas taken from KO mice fed with both
diets. These data provide evidence that ERα is involved in the
increase of NO• production induced by polyphenols.
In the heart, although not statistically significant, EPR
measurement revealed a reduction of 45% in NO• production
in WT mice fed with WD. Polyphenols did not significantly
modify NO• production in WT in both SD and WD mice. In
ERα-deficient mice, NO• production did not change independent
of diet and polyphenol supplementation (Figure 5B).
NO• production in both visceral and subcutaneous adipose
tissue was not significantly different, independent of both diets
and strains (Figures 5C,D).
In WT, WD significantly reduced hepatic NO• production
(71%) compared to SD-fed mice (P < 0.00001) (Figure 5E).
Polyphenols reduced NO• levels (52%) in SD-fed mice
(P = 0.0006); however, it enhanced NO• production (42%)
in WD-fed mice (P = 0.0303). Deletion of ERα profoundly
decreased NO• production (71%) in SD-fed mice (P < 0.00001).
In ERα deficient mice, WD did not significantly modify NO•
production compared to SD-fed mice. In WD-fed ERα deficient
mice, supplementation of polyphenols further reduced NO•
production (∼40%) (P = 0.0238). These results suggest that
polyphenols enhanced NO• bioavailability in the liver of WD-fed
mice through an ERα-dependent mechanism.
Effect of Polyphenols on ROS Production
In WT mice, ROS production was greater in aortas taken from
WD-fed mice compared to SD group (P = 0.0001) (Figure 6A).
Polyphenols did not modify oxidative stress in WT SD mice,
but it completely prevented the increase of ROS induced by WD
(P = 0.001). In KO mice, no changes in ROS production were
observed (Figure 6B). These data suggest that the polyphenol-
induced prevention of oxidative stress in aorta was dependent on
ERα.
Reactive oxygen species production in the heart of WT
mice fed with WD was greater than in SD mice (P = 0.0351)
(Figure 6C). Interestingly, polyphenols decreased oxidative stress
in WD-fed mice (87%) (P = 0.0005). WD increased ROS
production in hearts from ERα-deficient mice (Figure 6D)
(P = 0.0005). Polyphenols was still effective in reducing ROS
production by 73% in hearts taken from ERα-deficient mice fed
with WD (P = 0.0001). These data suggest that polyphenols
exerts a protective effect against oxidative stress in the heart
independently of the presence of ERα.
Reactive oxygen species production was greater in visceral
adipose tissue taken from WD-fed mice compared to SD in WT
mice (P = 0.04) (Figure 6E). Polyphenols did not modify ROS
levels in WT SD mice; however, it completely prevented oxidative
stress induced by WD (68.5%) (P = 0.0029) (Figure 6E). In
KO mice, WD did not significantly increase ROS production
compared to SD. Polyphenols tended to enhance oxidative stress
in SD mice (62.5%), but it significantly (P = 0.0471) decreased
ROS levels in WD-fed mice (65.8%). These results suggest that
in visceral adipose tissue polyphenols reduced oxidative stress
independently of ERα.
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FIGURE 2 | (A) Glucose, (B) triglycerides, (C) cholesterol plasma levels and (D) HDL/LDL ratio of ERα WT and KO mice receiving normal diet (SD), western diet
(WD), or SD and WD containing polyphenols (SD + polyphenols and WD + polyphenols, respectively) during 12 weeks. The data are given as the mean ± SEM.
Statistical analyses were performed by one-way ANOVA and Holm–Sidak’s post hoc test, ∗P < 0.05, ∗∗P < 0.01, ∗∗∗∗P < 0.0001.
FIGURE 3 | Concentration-response curves to (A,B) Ach and (C,D) 5-HT in aortic rings from ERα WT (A,C) and KO (B,D) mice receiving normal diet (SD),
western diet (WD), or SD and WD containing polyphenols (SD + polyphenols and WD + polyphenols, respectively) during 12 weeks. The data are expressed as the
mean ± SEM. Statistical analyses were performed by one-way ANOVA and Holm–Sidak’s post hoc test, ∗∗∗P < 0.001.
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TABLE 2 | Cardiac function following 12 weeks of diets.
WT KO
SD SD + Polyphenols WD WD + Polyphenols SD SD + Polyphenols WD WD + Polyphenols
LVEDD (mm) 3.5 ± 0.2 3.4 ± 0.2 3.7 ± 0.2 3.6 ± 0.1 3.4 ± 0.1 3.3 ± 0.1 3.2 ± 0.1 3.6 ± 0.2
LVESD (mm) 2.2 ± 0,1 2.2 ± 0.2 2.6 ± 0.2 2.3 ± 0.1 2.1 ± 0.1 2.4 ± 0.1 1.8 ± 0.1 2.6 ± 0.2
EF (%) 69.1 ± 2.8 70.9 ± 3.6 69.6 ± 2.8 66.4 ± 2.2 70.4 ± 1.1 60.8 ± 2.2 74.7 ± 2.3 65.1 ± 4.4
COI (mL/min/g) 0.8 ± 0.05 0.7 ± 0.07 0.7 ± 0.1 0.7 ± 0.05 0.8 ± 0.1 0.6 ± 0.1 0.8 ± 0.2 0.6 ± 0.03
The table shows the LVEDD, LVEDD, EF, COI in ERα WT or KO mice fed with SD, WD, SD + Polyphenols or WD + Polyphenols for 12 weeks. The data are given as the
mean ± SEM.
FIGURE 4 | Measurement of (A–D) enzymatic activities of mitochondrial respiratory chain complexes (CS, I, II, IV) in liver from ERα WT and KO mice receiving
normal diet (SD), western diet (WD), or SD and WD containing polyphenols (SD + polyphenols and WD + polyphenols, respectively) during 12 weeks. The data are
expressed as the mean ± SEM. Statistical analyses were performed by one-way ANOVA and Holm–Sidak’s post hoc test, **P < 0.01.
In WT mice, WD significantly (P = 0.0007) increased
ROS production in subcutaneous adipose tissue (86.7%) mice
compared to SD mice (Figure 6F). ROS level was significantly
(P = 0.0007) reduced upon polyphenol treatment (83%). In
KO mice, polyphenols completely prevented (82.3%) WD-
induced ROS production (P = 0.0463). These data suggest that
polyphenols prevented oxidative stress in subcutaneous adipose
tissue independently of ERα.
In WT mice, liver ROS production was greater (64%) in
those fed with WD compared to SD (P = 0.0094) (Figure 6G).
Polyphenols had no effect on SD-fed WT mice; however, it
significantly reduced oxidative stress (82%) in WD-fed WT
animals (P = 0.0006). ROS levels were not significantly different
in WT and KO mice fed with SD. Polyphenols did not affect
ROS production in both SD-fed and WD-fed KO mice. These
data suggest that polyphenols prevented oxidative stress in liver
dependently of ERα.
DISCUSSION
This study provides new and interesting evidence for the
beneficial effects of polyphenols on metabolic and cardiovascular
disorders induced by WD. First, polyphenols significantly
improved features of metabolic disorders induced by WD
including reduction of visceral and subcutaneous adipose
tissue accumulation and plasma triglyceride levels in WT mice.
Second, polyphenols increased NO• bioavailability resulting
from both enhanced NO• production and decreased ROS
levels i n the aorta and liver. Third, polyphenols decreased
oxidative stress in visceral and subcutaneous adipose tissues
and heart. Fourth, deletion of ERα prevented the beneficial
effects induced by supplementation with polyphenols in
WD-fed mice. Indeed, we clearly demonstrated that the
reduction of adiposity, and NO• bioavailability, as well as, the
improved activity of some hepatic mitochondrial complexes
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FIGURE 5 | Measurement of in situ NO• productions by electron paramagnetic resonance in aorta (A), heart (B), visceral (C) and subcutaneous (D)
adipose tissue, and liver (E) from ERα WT and KO mice receiving normal diet (SD), western diet (WD), or SD and WD containing polyphenols during 12 weeks. The
data are expressed as the mean ± SEM. Statistical analyses were performed by one-way ANOVA and Holm–Sidak’s post hoc test, ∗P < 0.05, ∗∗P < 0.01,
∗∗∗P < 0.001.
are mediated via an ERα-dependent mechanism. On the
other hand, deletion of ERα had no effect on the ability of
polyphenols to decrease oxidative stress and the accumulation
of subcutaneous adipose tissue, and to reduce oxidative stress
of in the visceral adipose tissue and heart from mice fed with
WD.
As expected, WD increased body weight gain more than
SD. This is associated with increased fat accumulation, plasma
glucose, triglycerides and cholesterol levels. Additionally, it
caused oxidative stress in vascular, cardiac, adipose and hepatic
tissues.
Here, we showed that polyphenols were not able to
significantly decrease weight gain. This finding concurs with
a parallel study using the same experimental protocol on
mice treated with polyphenols from grape seed (unpublished
results) and a previous study on Zucker fatty rats treated
with polyphenols extract at the dose of 20 mg/kg/day during
8 weeks (Agouni et al., 2009). Furthermore, 6 weeks of high-
fructose diet and simultaneous administration of 50 mg/kg/day
or 21 mg/kg/day of the same composition of polyphenols did
not modify rat body weight (Al-Awwadi et al., 2004, 2005).
Here, we have shown that polyphenols decreased adiposity in
particular visceral adipose tissue accumulation, in WT mice.
Dietary polyphenols may exert their effects on adipose tissue
through one or more signaling and transcriptional pathways
potentially including those mediated by NF-κB, AMPK, PPARγ,
and PGC-1α (Wang et al., 2014). Among the classes of
polyphenols contained in red wine, flavan-3-ols, flavonols and
antocyanins have been described to act on adipose tissue.
Notably catechins, especially EGCG, have an anti-adipogenic
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FIGURE 6 | Measurement of in situ ROS productions by electron paramagnetic resonance in aorta (A,B), heart (C,D), visceral (E) and subcutaneous (F)
adipose tissue, and liver (G) from ERα WT and KO mice receiving normal diet (SD), western diet (WD), or SD and WD containing polyphenols during 12 weeks. The
data are expressed as the mean ± SEM. Statistical analyses were performed by one-way ANOVA and Holm–Sidak’s post hoc test, ∗P < 0.05, ∗∗P < 0.01,
∗∗∗P < 0.001.
effect via ERK- and CDK-dependent signaling pathway, as
well as activation of AMPK and inhibition of lipogenic
enzymes (Moon et al., 2007). The flavanols, quercetin and
anthocyanins (both at 0.01 mol/kg diet), decreased mesenteric
adipose tissue weight in mice fed a high-fat diet for 12 weeks
(Hoek-van den Hil et al., 2015). Accordingly, the proposed
mechanism underlying the anti-obesity effect exhibited by
anthocyanins was mainly mediated by inhibition of preadipocyte
proliferation and lipid accumulation during differentiation
and reduction of basal lipolysis in 3T3-L1 cells (Kim et al.,
2012).
The present study also demonstrated that polyphenols
decreased triglyceride plasma levels, which was already reported
(Agouni et al., 2009). The extracts used in both studies
shared five classes of polyphenols (flavan-3-ols, hydroxycinnamic
acids, flavonols, anthocyanins and proanthocyanidins). It can
be hypothesized that these classes of polyphenols trigger the
decrease of triglyceridemia.
With regards to cardiac function, mice receiving WD did not
develop obesity-induced ventricular hypertrophy and diastolic
dysfunction as evidenced by echocardiography evaluations. This
was in accordance with a previous study showing that mice fed
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FIGURE 7 | In WD-fed mice, dietary supplementation with polyphenols reduced aortic ROS, enhanced NO• bioavailability in aorta and liver; and
reduced visceral adipose tissue accumulation via an ERα-dependent mechanism. Polyphenols decreased plasma triglycerides, subcutaneous fat
accumulation and ROS in adipose tissues, liver and heart independent of ERα. Hence, effects generated by polyphenols attenuate most features of metabolic
dysfunctions partially via ERα.
with high-fat diet were unable to recapitulate defects in cardiac
function (Brainard et al., 2013). It is possible that the model
used in this study represents an early stage of cardiac disease,
without the onset of irreversible damage due to hypertrophy
or cardiac failure. Although polyphenols did not significantly
modify the decreased of cardiac NO• production, it improved
WD-induced oxidative stress. Also, in a rat model of metabolic
syndrome, polyphenols such as catechin, resveratrol, delphinidin,
and gallic acid prevent cardiac ROS overproduction and NADPH
overexpression (for review see Le Lay et al., 2014). Moreover,
ROS reduction could be explained by the intrinsic capacity of
polyphenols to scavenge ROS or alternatively by their ability to
modulate expression and activity of antioxidant enzymes.
With regard to vascular function, although polyphenols did
not alter responses to Ach and 5-HT, it enhanced NO• production
and reduced superoxide anions in aortas leading to increase NO•
bioavailability., a notion compatible with our previous data in
Zucker fatty rats (Agouni et al., 2009). Indeed, polyphenols were
able to enhance NO• bioavailability in aortas from Zucker fatty
rats resulting from increased NO• production through enhanced
endothelial NOS activity and reduced superoxide anion release
via decreased expression of NADPH oxidase membrane sub-unit,
Nox-1 (Agouni et al., 2009).
In subcutaneous and visceral adipose tissues, polyphenols
were able to completely prevent oxidative stress induced by WD
without a significant effect on NO• level. In line with these results,
flavonoids such as quercetin, epicatechin and procyanidins,
and phenolic acids protect 3T3-L1 preadipocytes from ROS
production by enhancing superoxide dismutase antioxidant
enzyme gene expression (Marimoutou et al., 2015).
Furthermore, current reports show that polyphenols were
able to correct hepatic abnormalities described in obesity, such
as impaired NO• production, mitochondrial energy metabolism
(Holmstrom et al., 2012) and exaggerated oxidative stress.
Emerging evidence suggests that oxidative stress and altered
redox balance play a crucial part in the pathogenesis of obesity-
related hepatic complications, including steatosis, steatohepatitis
and fibrosis, all involving mitochondrial dysfunction. Alterations
in the oxidative phosphorylation pathways in liver mitochondria
have been reported in various models of obesity with some
conflicting results concerning respiratory chain complex
(Crescenzo et al., 2008; Vial et al., 2011). It has been shown
that dietary supplementation with curcumin diminished
mitochondrial dysfunction in the liver of db/db mice. This is
likely to be due to decreasing lipid peroxidation, resulting in an
increase in ATPase activity, restoration of oxygen consumption
and NO• synthesis (Soto-Urquieta et al., 2014). It has been
reported that high-fat diet affected the activity of all complexes
of the respiratory chain in mouse liver (Mingorance et al., 2012).
Our results are consistent with the latter at least with the reduced
activity of complex II associated with a non-significant decrease
of CS activity, supporting either an intrinsic mitochondrial
dysfunction or a lower mitochondrial number. Whatever the
correct explanation, it is important to note that treatment with
polyphenols led to a correction of hepatic complex II activity, as
well as NO• and ROS production.
Here, we provide evidence that the alpha isoform of ER
participates in the protective in vivo effects of polyphenols
against WD-induced metabolic defects especially on vascular
and liver nitrative stresses and visceral adiposity. It is well
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known that estrogenic signaling prevents accumulation of
visceral fat, increases central sensitivity to leptin, increases the
expression of insulin receptors in adipocytes, and decreases the
lipogenic activity of lipoprotein lipase in adipose tissue, thus
preventing the development of obesity and insulin resistance
(Clegg et al., 2006). Accordingly, lowering of adiposity and
visceral fat mass accumulation, improvement of vascular function
and NO• bioavailability are mediated via an ERα-dependent
mechanism. This notion is congruent with previous data showing
that polyphenols compounds exert vascular protection and that
this effect requires ERα (Chalopin et al., 2010).
Taken together, these results reveal a scenario in which
supplementation of polyphenols during a WD exerts an
integrative response able to attenuate most features of metabolic
dysfunctions; it also underscores the importance of ERα
activation on some of these protective effects including
vascular and liver nitrative stresses and visceral adiposity
(Figure 7). Furthermore, it highlights an additional mechanism
of polyphenols to reduce oxidative stress in different tissues
involved in obesity-related disorders. Therefore, this study points
to the therapeutic potential of red wine extract in metabolic and
cardiovascular alterations linked to excessive energy intake.
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